Bank Of Hawaii Astrazeneca PLC Transaction History

Bank Of Hawaii

$2.38 Billion
Q3 2024

A detailed history of Bank Of Hawaii transactions in Astrazeneca PLC stock. As of the latest transaction made, Bank Of Hawaii holds 9,088 shares of AZN stock, worth $602,534. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,088

Previous 10,423 12.81%

Holding current value

$602,534

Previous $812,000 12.81%

% of portfolio

0.03%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $102,354 - $116,972	-1,335 Reduced 12.81%	9,088 $708,000
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $22,849 - $27,643	-342 Reduced 3.18%	10,423 $812,000
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $120,290 - $137,122	-1,971 Reduced 15.48%	10,765 $729,000
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $193,653 - $216,777	-3,129 Reduced 19.72%	12,736 $857,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $100,776 - $111,421	1,554 Added 10.86%	15,865 $1.07 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $39,848 - $43,211	570 Added 4.15%	14,311 $1.02 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $170,062 - $192,818	2,693 Added 24.38%	13,741 $953,000
Q4 2022 Jan 30, 2023	SELL	$54.21 - $70.44 $238,198 - $309,513	-4,394 Reduced 28.45%	11,048 $749,000
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $627,809 - $1.61 Million	-11,841 Reduced 43.4%	15,442 $847,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $121,897 - $146,334	-2,057 Reduced 7.01%	27,283 $1.8 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1,615 - $1,946	29 Added 0.1%	29,340 $1.95 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $7,886 - $9,319	-146 Reduced 0.5%	29,311 $1.71 Million
Q3 2021 Nov 08, 2021	SELL	$55.56 - $60.79 $30,502 - $33,373	-549 Reduced 1.83%	29,457 $1.77 Million
Q2 2021 Jul 22, 2021	SELL	$48.42 - $60.18 $141,095 - $175,364	-2,914 Reduced 8.85%	30,006 $1.8 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $40,746 - $47,036	-864 Reduced 2.56%	32,920 $1.64 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $303,929 - $363,437	-6,264 Reduced 15.64%	33,784 $1.69 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $168,709 - $194,236	-3,179 Reduced 7.35%	40,048 $2.2 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $449,877 - $577,325	-10,438 Reduced 19.45%	43,227 $2.29 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $84,536 - $114,825	-2,237 Reduced 4.0%	53,665 $2.4 Million
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $83,943 - $99,759	-1,977 Reduced 3.42%	55,902 $2.79 Million
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $73,981 - $83,846	-1,844 Reduced 3.09%	57,879 $2.58 Million
Q2 2019 Aug 15, 2019	SELL	$37.28 - $41.68 $592,789 - $662,753	-15,901 Reduced 21.03%	59,723 $2.47 Million
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $301,665 - $365,670	-8,500 Reduced 10.1%	75,624 $3.06 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $321,234 - $361,585	-8,715 Reduced 9.39%	84,124 $3.2 Million
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $190,519 - $217,705	-5,481 Reduced 5.57%	92,839 $3.67 Million
Q2 2018 Aug 06, 2018	SELL	$34.55 - $37.05 $9,328 - $10,003	-270 Reduced 0.27%	98,320 $3.45 Million
Q1 2018 May 04, 2018	BUY	$32.97 - $36.63 $29,046 - $32,271	881 Added 0.9%	98,590 $3.45 Million
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $68,480 - $74,220	2,134 Added 2.23%	97,709 $3.39 Million
Q3 2017 Nov 03, 2017	SELL	$28.96 - $34.0 $381,837 - $448,290	-13,185 Reduced 12.12%	95,575 $3.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	108,760	108,760 $3.71 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.

Account